ALEXION PHARMACEUTICALS, INC. 3 SEC Filings

Filed On	Filing
23 Jul 2020	Form 3: Alexion PHARMACEUTICALS, Inc., 10% owner · Inozyme Pharma, Inc.
05 Nov 2019	Form 3: Carino Tanisha, EVP & CCAO No securities owned
19 Feb 2019	Form 3: Bazarko Daniel, SVP, Controller, CAO Holds 243 shares of Common Stock, par value $.0001 per share
19 Feb 2019	Form 3: Sarin Aradhana, Chief Strategy & Business Off Holds 10,478 shares of Common Stock, par value $.0001 per share
22 Feb 2018	Form 3: Chiniara Ellen, EVP & General Counsel No securities owned
08 Feb 2018	Form 3: Reinsdorf Judith A, Director No securities owned
01 Feb 2018	Form 3: Dunsire Deborah, Director No securities owned
15 Nov 2017	Form 3: Nader Francois, Director No securities owned
22 Sep 2017	Form 3: Friedman Paul A, Director No securities owned
12 Jul 2017	Form 3: Clancy Paul J, EVP, Chief Financial Officer No securities owned
09 Jun 2017	Form 3: Goff Brian, EVP & Chief Commercial Officer No securities owned
09 Jun 2017	Form 3: Franchini Indrani Lall, EVP, Chief Compliance Officer No securities owned
09 Jun 2017	Form 3: Orloff John J, EVP, Research & Development No securities owned
09 Jun 2017	Form 3: Law Anne-marie, EVP and CHRO No securities owned
29 Mar 2017	Form 3: Hantson Ludwig, Director No securities owned
13 Dec 2016	Form 3: Anderson David J, EVP, Chief Financial Officer No securities owned
08 Oct 2015	Form 3: Wagner Heidi L, SVP, Global Government Affairs Holds 25,916 shares of Common Stock, par value $.0001 per share
29 Jun 2015	Form 3: Alexion Pharmaceuticals Inc, 10% owner and 1 other · SYNAGEVA BIOPHARMA CORP Holds 21,021,124 shares of Common stock, par value $0.001 per share, of Synageva
24 Jun 2015	Form 3: Baker Felix, Director and 5 others No securities owned
12 Feb 2015	Form 3: Thiel Carsten, SVP, EMEA & Asia Pacific Holds 26,000 shares of Common Stock, par value $.0001 per share

Comments